Stifel Financial
BIOL

Stifel Financial’s Biolase, Inc. BIOL Stock Holding History

Stifel Financial’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2
Closed -$23K – 2531
2016
Q2 		$23K Hold
2
– – ﹤0.01% 2476
2016
Q1 		$26K Hold
2
– – ﹤0.01% 2183
2015
Q4 		$25K Hold
2
– – ﹤0.01% 2304
2015
Q3 		$24K Sell
2
-6
-75% -$112K ﹤0.01% 2209
2015
Q2 		$147K Buy
8
+6
+300% +$146K ﹤0.01% 2224
2015
Q1 		$51K Hold
2
– – ﹤0.01% 2238
2014
Q4 		$69K Hold
2
– – ﹤0.01% 2213
2014
Q3 		$47K Buy
2
+1
+100% +$28.3K ﹤0.01% 2154
2014
Q2 		$40K Sell
1
-1
-50% -$25.5K ﹤0.01% 2147
2014
Q1 		$52K Buy
+2
New +$69.8K ﹤0.01% 2039

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return

Stifel Financial's BIOL Position: Q3 2016 in Review

Stifel Financial sold out of Biolase, Inc. (BIOL) in Q3 2016, closing a stake of 2 shares — an estimated $23K sold.

Stifel Financial first reported a position in BIOL in Q1 2014 and held it in 10 quarters. The position peaked at $147K in Q2 2015. 31 funds tracked by Wall St. Rank hold BIOL as of Q3 2016.

  • Stifel Financial reported no remaining Biolase, Inc. position as of Q3 2016 after selling out during the quarter.
  • Stifel Financial sold 2 Biolase, Inc. shares in Q3 2016, an estimated $23K.
  • Stifel Financial first reported a position in Biolase, Inc. in Q1 2014 and held it in 10 quarters.
  • Stifel Financial's Biolase, Inc. position peaked at $147K in Q2 2015.
  • 31 funds tracked by Wall St. Rank held Biolase, Inc. as of Q3 2016.

Based on Stifel Financial's 13F filing for Q3 2016, filed 15 Nov 2016.